A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Clinical trial NCT03016091 · TERMINATED

Trial details

NCT number: NCT03016091
Sponsor: Rabin Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Meningioma Anaplastic Meningioma Hemangiopericytoma

Start date: 2018-01-01
Primary completion: 2022-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.